N-terminal pro-B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health Study.

[1]  A. Uy‐Evanado,et al.  Abstract 16081: What is the Societal Impact of Sudden Cardiac Death in the United States? , 2012 .

[2]  J. Gottdiener,et al.  Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing. , 2010, Journal of the American College of Cardiology.

[3]  G. B. Young,et al.  Clinical practice. Neurologic prognosis after cardiac arrest. , 2009, The New England journal of medicine.

[4]  S. Grundmann,et al.  Neurologic prognosis after cardiac arrest. , 2009, The New England journal of medicine.

[5]  N. Cook,et al.  Amino-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity C-Reactive Protein as Predictors of Sudden Cardiac Death Among Women , 2009, Circulation.

[6]  C. Callaway,et al.  Regional variation in out-of-hospital cardiac arrest incidence and outcome. , 2008, JAMA.

[7]  M. Pfeffer,et al.  Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial. , 2007, Journal of the American College of Cardiology.

[8]  M. Konstam.  Natriuretic peptides and cardiovascular events: more than a stretch. , 2007, JAMA.

[9]  D. Levy,et al.  Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.

[10]  T. Rea,et al.  Diabetes, glucose level, and risk of sudden cardiac death. , 2005, European heart journal.

[11]  P. Hildebrandt,et al.  N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. , 2005, JAMA.

[12]  L. Køber,et al.  N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. , 2005, The New England journal of medicine.

[13]  Daniel Levy,et al.  Plasma natriuretic peptide levels and the risk of cardiovascular events and death. , 2004, The New England journal of medicine.

[14]  G. Baxter.  The natriuretic peptides , 2004, Basic Research in Cardiology.

[15]  S. Chugh,et al.  Cardiac pathologic findings reveal a high rate of sudden cardiac death of undetermined etiology in younger women. , 2003, American heart journal.

[16]  R. Berger,et al.  B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure , 2002, Circulation.

[17]  George A. Mensah,et al.  Sudden Cardiac Death in the United States, 1989 to 1998 , 2001, Circulation.

[18]  J J Heger,et al.  Sudden cardiac death. , 1998, Circulation.

[19]  L H Kuller,et al.  Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. , 1995, Annals of epidemiology.

[20]  M. Cushman,et al.  Laboratory methods and quality assurance in the Cardiovascular Health Study. , 1995, Clinical chemistry.

[21]  R. Myerburg,et al.  Sudden Cardiac Death: Epidemiology, Transient Risk, and Intervention Assessment , 1993, Annals of Internal Medicine.

[22]  K. Inouye,et al.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. , 1991, The Journal of clinical investigation.

[23]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[24]  E. Rimm,et al.  Cardiac Sodium Channel Gene Variants and Sudden Cardiac Death in Women , 2008, Circulation.

[25]  H. S. Klopfenstein,et al.  Echocardiographic design of a multicenter investigation of free-living elderly subjects: the Cardiovascular Health Study. , 1992, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[26]  D L McGee,et al.  Epidemiology of sudden death: insights from the Framingham Study. , 1985, Cardiovascular clinics.